A股股票代码：601336 A股股票简称：新华保险 编号：2023-040号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 第七届监事会第三十七次会议决议公告 新华人寿保险股份有限公司监事会及全体监事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"公司"）于 2023 年 8 月 18 日以电 子邮件方式向全体监事发出第七届监事会第三十七次会议（以下简称"会议"） 通知和材料，会议于 2023 年 8 月 29 日在北京市以现场会议方式召开。会议应到 监事 4 人，现场出席会议 4 人。会议的召集、召开符合《中华人民共和国公司法》 《新华人寿保险股份有限公司章程》（以下简称"《公司章程》"）和《新华人寿保 险股份有限公司监事会议事规则》的有关规定，所作的决议合法、有效。 会议由监事长刘德斌主持，经与会监事审议和现场表决，形成如下会议决议： 审议通过了《关于 2023 年中期报告(A 股/H 股)的议案》。 2、公司上述报告内容真实、准确、完整地反映了公司的实际情况； 3、在提出本 ...

NEW CHINA LIFE INSURANCE COMPANY LTD. 01336 董事名單與其角色和職能 楊 雪 胡愛民 李琦強 新華人壽保險股份有限公司董事會（「董事會」）成員載列如下： 執行董事 張 泓 非執行董事 楊 毅 何興達 中國北京，2023年8月22日 - 2 - 獨立非執行董事 耿建新 馬耀添 賴觀榮 徐 徐 郭永清 - 1 - 董事會下設五個專業委員會，各專業委員會的組成如下： | | | 委員會 | | | 審計與關聯 交易控制 | 提名薪酬 | 風險管理與 消費者權益 | | --- | --- | --- | --- | --- | --- | --- | --- | | 董事 | | | 戰略委員會 | 投資委員會 | 委員會 | 委員會 | 保護委員會 | | 張 | 泓 | | M | M | | | | | 楊 | 毅 | | M | C | M | | | | 何興達 | | | | M | | | M | | 楊 | 雪 | | | | | M | M | | 胡愛民 | | | M | M | | | | | 李琦強 | | | | | M | M | M | | ...

| A股股票代码：601336 | A股股票简称：新华保险 编号：2023-038号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 李全先生在本公司任职期间，勤勉尽责、恪尽职守。本公司董事会向李全先 生所做出的贡献表示衷心感谢！ 特此公告。 新华人寿保险股份有限公司董事会 2023 年 8 月 22 日 新华人寿保险股份有限公司 关于董事长辞职的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"本公司"或"公司"）董事会于 2023 年 8 月 22 日收到董事长李全先生的辞职函，李全先生因年龄原因，辞去本公司 董事长、执行董事、首席执行官、董事会战略委员会主任委员、投资委员会委员、 风险管理与消费者权益保护委员会委员及其他一切职务。 李全先生的辞职函自送达本公司董事会之日起生效，根据相关法律法规的有 关规定，李全先生的辞任不会导致公司董事会成员人数低于法定最低人数，不会 影响公司董事会正常运行。李全先生确认其与本公司 ...

A股股票代码：601336 A股股票简称：新华保险 编号：2023-037号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 关于召开2023年中期业绩发布会的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 重要内容提示： 投资者可于 2023 年 8 月 28 日（星期一）23:59 前将相关问题通过电子邮 件的形式发送至新华人寿保险股份有限公司（以下简称"本公司"）投资者 关系邮箱：ir@newchinalife.com。 一、业绩发布会类型 本公司拟于 2023 年 8 月 30 日在上海证券交易所网站（www.sse.com.cn）披 露本公司 2023 年半年度报告。为了便于广大投资者更全面深入地了解本公司 2023 年中期业绩和经营情况，本公司拟于 2023 年 8 月 30 日 9:00-10:30 通过网 络直播的方式召开业绩发布会，就投资者普遍关心的问题进行交流。 二、业绩发布会召开的时间、地点 （三）网络直播地址：https://s.comein.cn ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不會就本通告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 承董事會命 新華人壽保險股份有限公司 李全 董事長 中國北京，二零二三年八月十四日 於本通告日期，本公司董事長、執行董事為李全；執行董事為張泓；非執行董 事為楊毅、何興達、楊雪、胡愛民和李琦強；獨立非執行董事為耿建新、馬耀 添、賴觀榮、徐徐和郭永清。 董事會會議通告 新華人壽保險股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈， 本公司將於二零二三年八月二十九日（星期二）舉行董事會會議，藉以(其中包 括)考慮及批准本公司及其附属公司截至二零二三年六月三十日止六個月之中期 業績及其發佈，以及處理其他事項。 ...

| A股股票代码：601336 | A股股票简称：新华保险 编号：2023-036号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 保费收入公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 根据中华人民共和国财政部《企业会计准则第 25 号——原保险合同》（财 会〔2006〕3 号）及《保险合同相关会计处理规定》（财会〔2009〕15 号），新华 人寿保险股份有限公司于 2023 年 1 月 1 日至 2023 年 7 月 31 日期间累计原保险 保费收入为人民币 11,956,867 万元。 上述原保险保费收入数据未经审计，提请投资者注意。 新华人寿保险股份有限公司董事会 特此公告。 2023 年 8 月 11 日 ...

Financial Performance - The company's operating revenue for Q1 2023 was RMB 29,005 million, representing a year-on-year increase of 17.49%[4] - The net profit attributable to shareholders of the parent company reached RMB 6,917 million, a significant increase of 114.8% compared to the same period last year[4][10] - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, was RMB 6,916 million, reflecting a 115.1% year-on-year growth[4][11] - The basic and diluted earnings per share for shareholders of the parent company were both RMB 2.22, up 115.5% from RMB 1.03 in the previous year[5][11] - The total comprehensive income for the three months ended March 31, 2023, was RMB 7,293 million, compared to RMB 1,287 million for the same period in 2022[26] Assets and Liabilities - The total assets at the end of Q1 2023 amounted to RMB 1,283,416 million, an increase of 5.69% from the end of the previous year[5] - The total liabilities as of March 31, 2023, amounted to RMB 1,161,792 million, an increase from RMB 1,116,940 million as of December 31, 2022[22] - The company's equity attributable to shareholders of the parent company was RMB 121,602 million, showing a growth of 24.1% compared to the previous year[5] - The total assets as of March 31, 2023, were RMB 1,283,416 million, an increase from RMB 1,267,721 million as of December 31, 2022[22] - The total assets of the company increased from RMB 1,181,619 million in 2022 to RMB 1,197,945 million in 2023, reflecting an increase of RMB 16,326 million[38] Investment Performance - The company's investment assets as of March 31, 2023, were RMB 1,234,624 million, which is a 6.7% increase year-on-year[7] - The company’s total investment assets reached 1,234.62 billion RMB as of March 31, 2023, with an annualized total investment return rate of 5.2%[18] - The investment income for the three months ended March 31, 2023, was a loss of RMB 1,755 million, compared to a profit of RMB 3,897 million in the same period of 2022[23] - The company’s financial investments included RMB 297,165 million in trading financial assets and RMB 240,155 million in debt investments[38] Cash Flow - The cash flow from operating activities was RMB 38,233 million, reflecting an increase of 8.0%[5] - The net cash flow from operating activities for the three months ended March 31, 2023, was RMB 38,233 million, compared to RMB 35,414 million for the same period in 2022, representing an increase of 4.6%[29] - The total cash inflow from investment activities was RMB 150,235 million for the three months ended March 31, 2023, compared to RMB 134,019 million in the same period of 2022, reflecting a growth of 12.1%[30] - The net cash outflow from investment activities was RMB 204,379 million for the three months ended March 31, 2023, compared to RMB 151,694 million in the same period of 2022, indicating a significant increase in investment expenditures[30] - The total cash inflow from financing activities was RMB 26,459 million for the three months ended March 31, 2023, compared to RMB 12,585 million in the same period of 2022, showing a substantial increase of 110.5%[33] Insurance Performance - The insurance service income for Q1 2023 was RMB 13,558 million, which represents a decrease of 4.4% compared to the same period last year[7] - In Q1 2023, the company achieved total premium income of 64.77 billion RMB, a slight decrease of 0.28% compared to the same period last year[14] - The first-year premium for long-term insurance was 9.35 billion RMB, representing a year-on-year growth of 9.2%[15] - The renewal premium increased by 2.5% to 43.42 billion RMB, while short-term insurance premium rose by 5.7% to 1.51 billion RMB[15] - The individual insurance channel's total premium decreased by 4.0% to 41.08 billion RMB, with a significant drop of 25.9% in first-year premiums[17] Accounting Standards and Reporting - The company implemented new accounting standards effective January 1, 2023, impacting the financial reporting of insurance contracts and financial instruments[19] - Total assets as of March 31, 2023, amounted to 1,283.42 billion RMB, reflecting the adoption of new financial reporting standards[21] - The company executed new accounting standards starting in 2023, which involved adjustments to the financial statements[38] Future Plans - The company plans to continue expanding its market presence and investing in new technologies to enhance its product offerings and improve operational efficiency[34]

A股股票代码：601336 A股股票简称：新华保险 编号：2023-018号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司关于 召开2023年第一季度业绩说明会的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 重要内容提示： 一、业绩说明会类型 （一）会议召开时间：2023 年 4 月 28 日（星期五）16:00-17:00 三、公司出席人员 公司高级管理人员 四、投资者参加方式 投资者可于 2023 年 4 月 28 日 16:00-17:00 登 录 上 证 路 演 中 心 1 会议召开时间：2023 年 4 月 28 日（星期五）16:00-17:00 会议召开方式：上证路演中心网络文字互动 网络互动地址：http://roadshow.sseinfo.com 新华人寿保险股份有限公司（以下简称"公司"）拟于 2023 年 4 月 28 日在 上海证券交易所网站（www.sse.com.cn）披露 2023 年第一季度报告。为了便于广 大投资者更全面深入地了解公 ...

Financial Performance - The company's total revenue for 2022 was 214,319 million RMB, a decrease of 3.6% compared to 222,380 million RMB in 2021[20]. - Net profit attributable to shareholders for 2022 was 9,822 million RMB, down 34.3% from 14,947 million RMB in 2021[20]. - The net cash flow from operating activities for 2022 was 89,385 million RMB, an increase of 21.0% compared to 73,853 million RMB in 2021[20]. - Total premium income reached CNY 163.1 billion, with renewal premiums increasing by 2.5% to CNY 119.7 billion[15]. - Insurance business revenue for 2022 was 163,099 million RMB, showing a slight decrease of 0.2% from 163,470 million RMB in 2021[20]. - The company's total assets reached 421.896 billion with a net profit of 5.221 billion, reflecting a strong financial position[80]. - Total assets amounted to CNY 1,255.0 billion, with investment assets at CNY 1,203.0 billion[12]. - The company's total liabilities increased by 13.0% to 1,152,139 million RMB, mainly due to the growth of insurance liability reserves[26]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of RMB 1.08 per share for the year 2022, totaling approximately RMB 3.369 billion, which accounts for 34.3% of the net profit attributable to shareholders[2]. - The company is committed to maintaining a minimum cash dividend ratio as stipulated in its articles of association[2]. Risk Management - The company has identified various risks including market risk, credit risk, insurance risk, operational risk, reputational risk, strategic risk, and liquidity risk, and has implemented measures to manage and control these risks effectively[2]. - The company will optimize its comprehensive risk management system to address potential risks and ensure effective operation[85]. - The company is facing risks from complex international environments and financial market pressures, including credit and liquidity risks[84]. Governance and Compliance - The financial report for 2022 has been audited by Deloitte and received a standard unqualified opinion[2]. - The company’s board of directors and senior management have confirmed the accuracy and completeness of the financial report, with no significant omissions or misleading statements[2]. - The company has ensured compliance with legal and regulatory requirements in its governance practices[156]. - The company has not faced any penalties from securities regulatory authorities for its current or former directors, supervisors, and senior management in the past three years[138]. Management and Board Structure - The board of directors consists of 12 members, including 2 executive directors, 5 non-executive directors, and 5 independent directors[155]. - The company has a performance salary system for senior management that includes basic salary, performance pay, and benefits[136]. - The company’s senior management remuneration is determined based on the company's operational status and performance evaluations, approved by the board of directors[136]. - The company appointed Mr. Wang Lianwen as vice president during the board meeting on December 8, 2022[113]. Employee and Training Initiatives - The company has a total workforce of 32,564 employees, with 57.6% in sales and sales management roles[140]. - In 2022, over 22,000 employees completed online training, with an average training duration of over 90 hours per person[143]. - Among the employees, 69.4% hold a bachelor's degree, while 6.0% have a postgraduate degree or higher[141]. Investment and Asset Management - The company invested over CNY 190 billion in strategic emerging industries, marking a 29% year-on-year increase[15]. - The net investment yield for the company's investment portfolio was 4.6%, with total investment income yield at 4.3%[58]. - The company’s equity investment dividend income surged by 92.3% to CNY 15,147 million from CNY 7,876 million in 2021[61]. Business Strategy and Future Outlook - The company aims to contribute to social economic recovery in 2023, focusing on steady progress and resilience[16]. - The company plans to enhance its long-term investment management capabilities and actively participate in the "third pillar" pension system development[20]. - The company plans to stabilize business scale and promote long-term, diversified business transformation in 2023[83]. Product and Market Performance - The individual insurance channel generated premium income of CNY 116,362 million, down 2.9% year-on-year[40]. - The bancassurance channel achieved premium income of CNY 43,931 million, an increase of 7.8% compared to CNY 40,737 million in 2021[40]. - The policyholder health insurance business generated premium income of CNY 7,620 million, up 48.5% year-on-year, covering 17.95 million customers, an increase of 108.2%[41]. Financial Ratios and Metrics - Core solvency adequacy ratio stood at 140.53%, while comprehensive solvency adequacy ratio was 238.20%[13]. - The debt-to-asset ratio increased to 91.8% from 90.4%, indicating a higher level of leverage[70]. - The total embedded value as of December 31, 2022, is CNY 255,582 million, slightly down from CNY 258,824 million in 2021[102].

Financial Performance - Total revenue for the third quarter was RMB 46,383 million, a decrease of 10.7% year-on-year[4] - Net profit attributable to shareholders of the parent company was RMB 3 million, down 99.8% compared to the same period last year[10] - The net profit excluding non-recurring gains and losses was RMB 18 million, a decrease of 98.8% year-on-year[4] - The basic and diluted earnings per share were both RMB 1.66, down 56.7% year-on-year[10] - The weighted average return on equity was 4.94%, a decrease of 6.56 percentage points compared to the previous year[5] - Net profit for the nine months ended September 30, 2022, was RMB 5,192 million, a decline of 56.5% from RMB 11,957 million in the same period of 2021[25] - The company’s total profit for the nine months ended September 30, 2022, was RMB 3,403 million, a decrease of 73.9% from RMB 13,061 million in the previous year[25] Assets and Liabilities - Total assets at the end of the reporting period reached RMB 1,195,213 million, an increase of 6.0% from the end of the previous year[5] - The total liabilities reached RMB 1,095,140 million, up from RMB 1,019,207 million at the end of 2021, indicating an increase of about 7.4%[23] - The total equity attributable to shareholders of the parent company was RMB 100,054 million, down from RMB 108,497 million at the end of 2021, reflecting a decrease of about 7.3%[23] - The insurance liabilities, including life insurance and health insurance reserves, totaled RMB 947,477 million, an increase from RMB 859,926 million at the end of 2021, representing a growth of approximately 10.2%[23] Investment Performance - Investment assets amounted to RMB 1,145,133 million, reflecting a growth of 5.8% year-on-year[7] - Annualized total investment return rate was 3.7%, down by 2.7 percentage points year-on-year[19] - Investment income decreased to RMB 35,762 million, down 26.6% from RMB 48,723 million in the previous year[25] Premium Income - The insurance business income for the first nine months was RMB 137,792 million, a slight increase of 0.9% year-on-year[7] - Total premium income reached RMB 137.79 billion, a year-on-year increase of 0.9%[15] - First-year premium for long-term insurance was RMB 15.72 billion, a decrease of 14.6% year-on-year[16] - Renewal premium amounted to RMB 98.99 billion, showing a growth of 2.5% compared to the previous year[16] - The individual insurance channel reported total premium income of RMB 96.88 billion, a decrease of 2.0% year-on-year[18] - The bancassurance channel achieved total premium income of RMB 38.58 billion, an increase of 9.3% year-on-year[18] - The group insurance channel's total premium income was RMB 2.34 billion, a decrease of 3.6% year-on-year[18] - The first-year premium for long-term insurance in the bancassurance channel was RMB 25.23 billion, an increase of 15.6% year-on-year[18] Cash Flow - Cash flow from operating activities increased to RMB 74,309 million, up 28.5% from RMB 57,798 million in the previous year[27] - Cash inflow from investment activities totaled RMB 342,709 million, an increase from RMB 327,879 million in the same period of 2021[27] - The company reported a net decrease in cash and cash equivalents of 3,988,000, compared to an increase of 474,000 in the same period last year[33] - The cash and cash equivalents at the end of the period were 11,471,000, down from 13,467,000 at the end of the previous period[33] Reserves and Provisions - The company increased life insurance reserves by RMB 2.28 billion and long-term health insurance reserves by RMB 2.67 billion due to changes in actuarial assumptions[20] - The company reported a significant increase in policyholder savings and investment funds, which reached RMB 66,955 million, up from RMB 57,691 million at the end of 2021, indicating a growth of approximately 16.5%[23] - The deferred income tax liabilities decreased to RMB 58 million from RMB 1,118 million at the end of 2021, a reduction of about 94.8%[23] Other Comprehensive Income - The company’s other comprehensive income after tax was RMB (9,240) million, compared to RMB (4,533) million in the same period of 2021[26]